CRDL.TO
Cardiol Therapeutics Inc
Price:  
2.04 
CAD
Volume:  
91,073.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CRDL.TO WACC - Weighted Average Cost of Capital

The WACC of Cardiol Therapeutics Inc (CRDL.TO) is 7.5%.

The Cost of Equity of Cardiol Therapeutics Inc (CRDL.TO) is 7.45%.
The Cost of Debt of Cardiol Therapeutics Inc (CRDL.TO) is 5.00%.

Range Selected
Cost of equity 4.60% - 10.30% 7.45%
Tax rate 25.90% - 26.50% 26.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.6% - 10.3% 7.5%
WACC

CRDL.TO WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.29 1
Additional risk adjustments 0.0% 0.5%
Cost of equity 4.60% 10.30%
Tax rate 25.90% 26.50%
Debt/Equity ratio 0 0
Cost of debt 5.00% 5.00%
After-tax WACC 4.6% 10.3%
Selected WACC 7.5%